midazolam and kava

midazolam has been researched along with kava in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gardner, SF; Gentry, WB; Gurley, BJ; Hubbard, MA; Khan, IA; Shah, A; Williams, DK	1
Gentry, WB; Gurley, BJ; Hartsfield, F; Hubbard, MA; Swain, A; Thaden, J; Tong, Y; Williams, DK	1

Trials

2 trial(s) available for midazolam and kava

Article	Year
In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:5 Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Capsules; Cimicifuga; Dietary Supplements; Drug Administration Schedule; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Patient Selection; Phenotype; Time Factors; Valerian	2005
Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo. Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1 Topics: Adult; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dietary Supplements; Enzyme Induction; Enzyme Inhibitors; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Models, Biological; Phenotype; Plant Preparations; Rifampin; Risk Assessment; Substrate Specificity	2008

Article

Year

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:5

Topics: Adult; Aryl Hydrocarbon Hydroxylases; Caffeine; Capsules; Cimicifuga; Dietary Supplements; Drug Administration Schedule; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Patient Selection; Phenotype; Time Factors; Valerian

2005

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.

Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:1

Topics: Adult; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dietary Supplements; Enzyme Induction; Enzyme Inhibitors; Female; Herb-Drug Interactions; Humans; Hydrastis; Kava; Male; Midazolam; Models, Biological; Phenotype; Plant Preparations; Rifampin; Risk Assessment; Substrate Specificity

2008